Product Images Naropin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Naropin NDC 63323-285 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

nov0h 0001 01

nov0h 0001 01

nov0h 0001 02

nov0h 0001 02

nov0h 0001 03

nov0h 0001 03

Naropin® (ropivacaine HCl Injection, USP) is a prescription medication used for nerve block and epidural procedures. Each milliliter of Naropin® contains 2mg of Ropivacaine HCI and Sodium chloride. The solution does not contain preservatives, and users are advised to consult the package insert for dosage and full prescribing information. It is important not to use Naropin® if the solution appears discolored or contains a precipitate. This medication should be stored at 68°F to 77°F, and the container closure is not made with natural rubber latex. However, the above text contains errors, the correct text should contain the expression "Consult package insert for dosage and full prescribing information", and the last line "Mid.by." is also an error. The correct line is "Lake Zurich, IL 60047, Fresenius Kabi".*

nov0h 0001 04

nov0h 0001 04

This is a product description for Naropin, which is an injection containing ropivacaine HCI. It has a strength of 0.5% S and is manufactured by Fresenius Kabi. The packaging does not contain natural rubber latex, and it is kept at controlled room temperature. The product is only available with a prescription, and Novaplus is a registered trademark of Vizient Inc.*

nov0h 0001 05

nov0h 0001 05

Naropin (Ropivacaine HCl Injection, USP) is a solution for Infiltration, Nerve Block, and Epidural Administration supplied in a pack of 25 single dose vials, and not for Intravenous Administration. Its composition of each mL includes Ropivacaine HCI 5 mg, Sodium chloride 8 mg, Sodium hydroxide and/or hydrochloric acid to adjust the pH104.010 6.0. The solution is preservative-free and the unused portion should be discarded. The container closure is not made with natural rubber latex. This product is manufactured by Fresenius Kabi. For dosage and complete prescribing information, please consult the package insert.*

nov0h 0001 06

nov0h 0001 06

Naropin® (ropivacaine HCI Injection, USP) is a medication that comes in a single-dose vial with 200 mg per 20 mL. It is intended for epidural administration only and should not be administered intravenously. The medication should be stored at 20° to 25°C and is a trademark of Fresenius Kabi USA, LLC. Novaplus is a registered trademark of Vizient, Inc. The medication is manufactured by Fresenius Kabi and has lot number 3 402796C.*

nov0h 0001 07

nov0h 0001 07

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.